VRAYLAR
Identification of Vraylar
| No description |
Google image searchProduct monograph
Active ingredient
cariprazine (cariprazine hydrochloride), 3 MG
DIN: 02526808
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: ABBVIE CORPORATION
Date: 14-MAY-2024
ATC:
- N05 — PSYCHOLEPTICS (ATC, ATC/DDD, )
- N05A — ANTIPSYCHOTICS (ATC, ATC/DDD)
- N05AX — Other antipsychotics (ATC, ATC/DDD)
- N05AX15 — CARIPRAZINE (ATC/DDD)
